Stay up to date on the issues impacting the industry and be the first to hear about news and changes at Rael & Letson.
Research shows that health care utilization—not just high prices—is the main driver of spending variation across U.S. counties. Learn how plan sponsors can address both cost and volume to improve value, and why local patterns matter more than ever.
Read moreInterest in psychedelic-assisted therapy is rising, but coverage in multiemployer plans remains rare. Learn how sponsors can evaluate this evolving space—and why communication is key to improving access, safety, and awareness.
Read moreDrug rebates are meant to lower costs, but limited transparency and misaligned incentives raise questions. Learn how employers can evaluate PBM practices and ensure their plan delivers real value and long-term savings.
Read moreBefore replacing a wellness program or vendor, you might want to check your communications. Even the best programs can face low engagement when there is poor or confusing outreach or issues accessing services.
Read moreWe are excited to welcome Martin Fornataro, Pharm.D., to our PBM Consulting team.
Read moreAfter a wave of FDA approvals, annual spending on CGTs is estimated to increase from $5.15 billion in 2020 to $25.3 billion in 2026! What does this mean for your plan?
Read moreWhy can't an actuary make up any number for a retiree health valuation liability - what's it matter?! Learn why it does matter if the actuary wants to stay an actuary.
Read moreHigh claims costs and the high demand of popular weight loss medications can lead to necessary plan exclusions, but is exclusion the right path?
Read moreWes Yoder discusses challenges plan sponsors face when introducing and managing retiree health and welfare plans in Benefits Magazine.
Read more